Michael A. Sherman

This profile gathers the share dealings of Michael A. Sherman across 2 companies, led by Chimerix Inc and Endocyte Inc. We count 8 filings; the first trade dates from 4 February 2016 and the latest from 21 April 2025.

On the market, this insider has only ever bought: 1 purchase, €12k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 4 share grants and 2 option exercises.

Most recently, on 21 April 2025, the filings show a transaction worth €646k in Chimerix Inc. The clock since the last published purchase (16 May 2023) now reads 1,251 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.